Indications and uses
For the relief of inflammatory symptoms
For the relief of inflammatory symptoms
Normal storage use. Do not use if tamper-evident seal is broken or removed.
Aconitum (200K), Anti-Interleukin-1 (6X, 30K), Apis (200K), Adrenal (8X, 200K), Belladonna (200K), Beta Endorphin (6X, 200K), Citric Acid (30K), Coelliac Plexus (8X, 200K), Bryonia (200K), Interleukin-10 (8X, 200K), Mesenchyme (6X, 200K), Natrum Pyruvicum (30K), Pineal (2, 30K), Pituitary Gland (6X, 200K), Pyrogenium (200K), Transforming Growth Factor-1 (5C, 30K), Transforming Growth Factor-3 (5C, 30K)
| Aconitum | Cell respiration |
| Anti-Interleukin-1 | Anti-inflammation |
| Apis | Anti-inflammation |
| Adrenal | Adrenal support |
| Belladonna | Drainage |
| Beta Endorphin | Pain relief |
| Citric Acid | Cell respiration |
| Coelliac Plexus | Neurological support |
| Bryonia | Drainage |
| Interleukin-10 | Anti-inflammation |
| Mesenchyme | Regeneration |
| Natrum Pyruvicum | Cell respiration |
| Pineal | Regeneration |
| Pituitary Gland | Regeneration |
| Pyrogenium | Drainage |
| Transforming Growth Factor-1 | Immune support |
| Transforming Growth Factor-3 | Regeneration |
For the relief of inflammatory symptoms
Stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. If pregnant or breastfeeding, ask a health care practitioner before use.
1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Keep this and all medicines out of reach of children.
20% Alcohol and 80% Water
Normal storage use.
Do not use if tamper-evident seal is broken or removed.
info@viatrexx.com
ITEM: VPC0279
NDC 63776-249-14
Homeopathic remedy
Infla
• For the relief of inflammatory symptoms
Oral spray
30ml 1 oz
Viatrexx™ Bio Incorporated
Manufactured by Viatrexx
www.viatrexx.com
Newark, DE 19713

Infla
30 ml
1 oz
Viatrexx™ Bio Incorporated
ITEM: VPC0279
NDC: 63776-249-14
INDICATIONS:
For the relief of inflammatory symptoms
DIRECTIONS:
1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Mfg. for
Viatrexx Bio Incorporated.
www.viatrexx.com
Newark, DE 19713

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63776-249-14 | 2024-01-30 | C162847 | 48780-1 | 1030e365-635e-111a-e063-dadaa90a10e2 | Infla |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63776-249-14 | Infla | 1 in 1 BOX | SPRAY | 1 | 4 | |
| 63776-249-14 | Infla | 30 mL in 1 BOTTLE, SPRAY | SPRAY | 30 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63776-249 | INFLA (ACONITUM NAPELLUS, ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT, APIS MELLIFERA, BOS TAURUS ADRENAL GLAND, SUS SCROFA ADRENAL GLAND, ATROPA BELLADONNA, METENKEFALIN, CITRIC ACID MONOHYDRATE, BOS TAURUS SOLAR PLEXUS, SUS SCROFA SOLAR PLEXUS, BRYONIA ALBA ROOT, INTERLEUKIN-10, BOS TAURUS MESENCHYME, SUS SCROFA MESENCHYME, SODIUM PYRUVATE, BOS TAURUS PINEAL GLAND, SUS SCROFA PINEAL GLAND, BOS TAURUS PITUITARY GLAND, SUS SCROFA PITUITARY GLAND, RANCID BEEF, TRANSFORMING GROWTH FACTOR BETA-1, AVOTERMIN) SPRAY [VIATREXX BIO INCORPORATED] | 4 | Legacy NDC, 2 package rows | 20221202_8bbe9853-f838-1204-2ab5-77bbdfd8f2f5.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aconitum Napellus | ACTIVE INGREDIENT | U0NQ8555JD | 1 | |
| Anti-interleukin-1.alpha. Immunoglobulin G Rabbit | ACTIVE INGREDIENT | ML4QRZ1HCL | 1 | |
| Apis Mellifera | ACTIVE INGREDIENT | 7S82P3R43Z | 1 | |
| Atropa Belladonna | ACTIVE INGREDIENT | WQZ3G9PF0H | 1 | |
| Avotermin | ACTIVE INGREDIENT | 2Q1GS25JWN | 1 | |
| Bos Taurus Adrenal Gland | ACTIVE INGREDIENT | M2776SWB29 | 1 | |
| Bos Taurus Mesenchyme | ACTIVE INGREDIENT | 3802H34QRI | 1 | |
| Bos Taurus Pineal Gland | ACTIVE INGREDIENT | Z7RM5NBH36 | 1 | |
| Bos Taurus Pituitary Gland | ACTIVE INGREDIENT | 7JM57I419K | 1 | |
| Bos Taurus Solar Plexus | ACTIVE INGREDIENT | Y8H8S1X8IB | 1 | |
| Bryonia Alba Root | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| Citric Acid Monohydrate | ACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| Interleukin-10 | ACTIVE INGREDIENT | 9SC4O216V9 | 1 | |
| Metenkefalin | ACTIVE INGREDIENT | 9JEZ9OD3AS | 1 | |
| Rancid Beef | ACTIVE INGREDIENT | 29SUH5R3HU | 1 | |
| Sodium Pyruvate | ACTIVE INGREDIENT | POD38AIF08 | 1 | |
| Sus Scrofa Adrenal Gland | ACTIVE INGREDIENT | 398IYQ16YV | 1 | |
| Sus Scrofa Mesenchyme | ACTIVE INGREDIENT | UH52A16DZB | 1 | |
| Sus Scrofa Pineal Gland | ACTIVE INGREDIENT | 050QZ2EDK7 | 1 | |
| Sus Scrofa Pituitary Gland | ACTIVE INGREDIENT | E8S87O660T | 1 | |
| Sus Scrofa Solar Plexus | ACTIVE INGREDIENT | WN6M3MGG1X | 1 | |
| Transforming Growth Factor Beta-1 | ACTIVE INGREDIENT | T7D25J14LT | 1 | |
| Aconitum Napellus | ACTIVE MOIETY | U0NQ8555JD | 1 | |
| Anhydrous Citric Acid | ACTIVE MOIETY | XF417D3PSL | 1 | |
| Anti-interleukin-1.alpha. Immunoglobulin G Rabbit | ACTIVE MOIETY | ML4QRZ1HCL | 1 | |
| Apis Mellifera | ACTIVE MOIETY | 7S82P3R43Z | 1 | |
| Atropa Belladonna | ACTIVE MOIETY | WQZ3G9PF0H | 1 | |
| Avotermin | ACTIVE MOIETY | 2Q1GS25JWN | 1 | |
| Bos Taurus Adrenal Gland | ACTIVE MOIETY | M2776SWB29 | 1 | |
| Bos Taurus Mesenchyme | ACTIVE MOIETY | 3802H34QRI | 1 | |
| Bos Taurus Pineal Gland | ACTIVE MOIETY | Z7RM5NBH36 | 1 | |
| Bos Taurus Pituitary Gland | ACTIVE MOIETY | 7JM57I419K | 1 | |
| Bos Taurus Solar Plexus | ACTIVE MOIETY | Y8H8S1X8IB | 1 | |
| Bryonia Alba Root | ACTIVE MOIETY | T7J046YI2B | 1 | |
| Interleukin-10 | ACTIVE MOIETY | 9SC4O216V9 | 1 | |
| Metenkefalin | ACTIVE MOIETY | 9JEZ9OD3AS | 1 | |
| Pyruvic Acid | ACTIVE MOIETY | 8558G7RUTR | 1 | |
| Rancid Beef | ACTIVE MOIETY | 29SUH5R3HU | 1 | |
| Sus Scrofa Adrenal Gland | ACTIVE MOIETY | 398IYQ16YV | 1 | |
| Sus Scrofa Mesenchyme | ACTIVE MOIETY | UH52A16DZB | 1 | |
| Sus Scrofa Pineal Gland | ACTIVE MOIETY | 050QZ2EDK7 | 1 | |
| Sus Scrofa Pituitary Gland | ACTIVE MOIETY | E8S87O660T | 1 | |
| Sus Scrofa Solar Plexus | ACTIVE MOIETY | WN6M3MGG1X | 1 | |
| Transforming Growth Factor Beta-1 | ACTIVE MOIETY | T7D25J14LT | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63776-249 | 63776-249-14 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| eeb5b067-49c8-4097-e053-2a95a90ab02f | 8bbe9853-f838-1204-2ab5-77bbdfd8f2f5 | 2022-11-30 | Warnings | eeb5b067-49c8-4097-e053-2a95a90ab02f 8bbe9853-f838-1204-2ab5-77bbdfd8f2f5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.